Kerry Clem
2021
In 2021, Kerry Clem earned a total compensation of $662.4K as Chief Commercial Officer at Acorda Therapeutics, a 10% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $168,698 |
|---|---|
| Salary | $415,000 |
| Stock Awards | $69,976 |
| Other | $8,700 |
| Total | $662,374 |
Clem received $415K in salary, accounting for 63% of the total pay in 2021.
Clem also received $168.7K in non-equity incentive plan, $70K in stock awards and $8.7K in other compensation.
Rankings
In 2021, Kerry Clem's compensation ranked 10,067th out of 12,415 executives tracked by ExecPay. In other words, Clem earned more than 18.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,067 out of 12,415 | 19th |
Division Manufacturing | 4,459 out of 5,505 | 19th |
Major group Chemicals And Allied Products | 1,988 out of 2,375 | 16th |
Industry group Drugs | 1,766 out of 2,096 | 16th |
Industry Biological Products, Except Diagnostic Substances | 382 out of 449 | 15th |
Pay ratio
| Kerry Clem's Pay | $662,374 |
|---|---|
| Median Employee's Pay | $226,642 |
| Pay Ratio | to 1 |
In 2021, the annual total compensation of Kerry Clem was $662,374.
The annual total compensation of the median employee at Acorda Therapeutics was $226,642.
The ratio of Kerry Clem's pay to the pay of median employee was therefore to one.
Source: SEC filing on April 27, 2023.
Clem's colleagues
We found four more compensation records of executives who worked with Kerry Clem at Acorda Therapeutics in 2021.